Advances in immunology: Complement (first of two parts)

New England Journal of Medicine

Volumn 344, Issue 14, 2001, Pages 1058-1066

  Walport, Mark J ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR; CARRIER PROTEIN; CD59 ANTIGEN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN; MANNOSE BINDING LECTIN; NEPHRITIC FACTOR;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; BACTERIAL INFECTION; CHEMOTAXIS; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEFICIENCY; CYTOLYSIS; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL MEMORY; INFLAMMATION; OPSONIZATION; PHAGOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; GENETICS; IMMUNOLOGY; INFECTION; METABOLISM; NEISSERIACEAE INFECTION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHYSIOLOGY;

ANTIGENS, CD59; CARRIER PROTEINS; COMPLEMENT ACTIVATION; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C3 NEPHRITIC FACTOR; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; INFECTION; MANNOSE-BINDING LECTINS; NEISSERIACEAE INFECTIONS;

EID: 0035810399     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200104053441406     Document Type: Review

References (61)

1. Complement deficiency states and infection: Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency
2. Inherited deficiencies of the terminal components of human complement
3. Heberden oration 1986: Complement - Friend or foe?
4. Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections
5. Deficiency of the sixth component of complement and susceptibility to Neisseria meningitidis infections: Studies in 10 families and five isolated cases
6. Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release
7. Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors
8. Inherited deficiency of ninth component of complement: An increased risk of meningococcal meningitis
9. Defective opsonization: A common immunity deficiency
10. A defect of the alternative pathway of complement
11. Association of low levels of mannan-binding protein with a common defect of opsonisation
12. Molecular basis of opsonic defect in immunodeficient children
13. Mannose-binding lectin: The pluripotent molecule of the innate immune system
14. The mannose receptor is a pattern recognition receptor involved in host defense
15. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
16. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America
17. Proteolytic activities of two types of mannose-binding lectin-associated serine protease
18. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
19. Mannose-binding protein B allele confers protection against tuberculous meningitis
20. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans
21. Dual role of mannan-binding protein in infections: Another case of heterosis?
22. A macrophage invasion mechanism of pathogenic mycobacteria
23. Human complement regulators: A major target for pathogenic microorganisms
24. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
25. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d
26. Complement receptors in HIV infection
27. Complement-related proteins in pathogenic organisms
28. Antiphagocytic activity of streptococcal M protein: Selective binding of complement control protein factor H
29. Mechanism of action of the group A streptococcal C5a inactivator
30. Viral interference with antibody and complement
31. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1
32. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement
33. Inhibition of the complement cascade by the major secretory protein of vaccinia virus
34. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells
35. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1
36. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement
37. C3 nephritic factor and SLE: Report of four cases and review of the literature
38. Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia
39. Mesangiocapillary glomerulonephritis
40. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue
41. Lipodystrophy in MCGN type II: The clue to links between the adipocyte and the complement system
42. H deficiency in two brothers with atypical dense intramembranous deposit disease
43. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H
44. Familial hemolytic-uremic syndrome and homozygous factor H deficiency
45. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Role of factor H abnormalities: Italian registry of familial and recurrent hemolytic uremic syndrome/thrombotic thrombocytopenic purpura
46. Partial H (beta 1H) deficiency and glomerulonephritis in two families
47. Hypocomplementaemia due to a genetic deficiency of beta 1H globulin
48. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency
49. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate
50. Plasma bradykinin in angio-oedema
51. 444→His) mutation
52. CpG mutations in the reactive site of human C1 inhibitor
53. An IgG autoantibody which inactivates C1-inhibitor
54. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema
55. Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria
56. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria
57. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria
58. Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype
59. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria
60. Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor)
61. The Inab phenotype: Characterization of the membrane protein and complement regulatory defect